Bil J - Search Results

1

Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.

Gil RJ, Bil J, Džavík V, Vassilev D, Kern A, Formuszewicz R, Zalewska-Adamiec M, Dobrzycki S. Gil RJ, et al. Among authors: bil j. Can J Cardiol. 2015 May;31(5):671-8. doi: 10.1016/j.cjca.2014.12.024. Epub 2014 Dec 24. Can J Cardiol. 2015. PMID: 25828372 Clinical Trial.

2

[The regulatory mechanisms of protein expression in heart failure patients' cardiomyocytes. The ubiquitin-proteasome system. Autophagy].

Pawlak A, Bil J, Gil RJ. Pawlak A, et al. Among authors: bil j. Kardiol Pol. 2012;70(11):1170-6. Kardiol Pol. 2012. PMID: 23180530 Review. Polish. No abstract available.

3

Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.

Gil RJ, Bil J, Michałek A, Vassiliev D, Costa RA. Gil RJ, et al. Among authors: bil j. Int J Cardiovasc Imaging. 2013 Dec;29(8):1667-76. doi: 10.1007/s10554-013-0264-0. Epub 2013 Jul 19. Int J Cardiovasc Imaging. 2013. PMID: 23868287 Free PMC article. Clinical Trial.

4

Optical coherence tomography criteria for defining functional severity of intermediate lesions: a comparative study with FFR.

Pawlowski T, Prati F, Kulawik T, Ficarra E, Bil J, Gil R. Pawlowski T, et al. Among authors: bil j. Int J Cardiovasc Imaging. 2013 Dec;29(8):1685-91. doi: 10.1007/s10554-013-0283-x. Epub 2013 Sep 3. Int J Cardiovasc Imaging. 2013. PMID: 23999603

5

Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.

Bil J, Gil RJ, Vassilev D, Rzezak J, Kulawik T, Pawlowski T. Bil J, et al. J Interv Cardiol. 2014 Jun;27(3):242-51. doi: 10.1111/joic.12119. Epub 2014 Apr 7. J Interv Cardiol. 2014. PMID: 24708143 Free article.

6

First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.

Gil RJ, Bil J, Vassiliev D, Iñigo Garcia LA. Gil RJ, et al. Among authors: bil j. J Interv Cardiol. 2015 Feb;28(1):51-60. doi: 10.1111/joic.12180. J Interv Cardiol. 2015. PMID: 25689548 Free article.

7

The BiOSS stent.

Gil RJ, Bil J, Vassilev D. Gil RJ, et al. Among authors: bil j. EuroIntervention. 2015;11 Suppl V:V153-4. doi: 10.4244/EIJV11SVA37. EuroIntervention. 2015. PMID: 25983155 Free article. No abstract available.

8

Coronary spasm revascularized with a bioresorbable vascular scaffold.

Bil J, Pawlowski T, Gil RJ. Bil J, et al. Coron Artery Dis. 2015 Nov;26(7):634-6. doi: 10.1097/MCA.0000000000000297. Coron Artery Dis. 2015. PMID: 26267749 No abstract available.

9

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry.

Gil RJ, Bil J, Grundeken MJ, Iñigo Garcia LA, Vassilev D, Kern A, Pawłowski T, Wykrzykowska JJ, Serruys PW. Gil RJ, et al. Among authors: bil j. EuroIntervention. 2016 Nov 20;12(10):1246-1254. doi: 10.4244/EIJY15M10_05. EuroIntervention. 2016. PMID: 26465375 Free article.

10

Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis.

Bil J, Gil RJ, Kern A, Pawłowski T, Seweryniak P, Śliwiński Z. Bil J, et al. BMC Cardiovasc Disord. 2015 Nov 14;15:150. doi: 10.1186/s12872-015-0139-5. BMC Cardiovasc Disord. 2015. PMID: 26573577 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters